T1	PrimaryOutcome 62 94	time to clinical recovery (TTCR)
T2	OutcomeDefinition 107 165	the number of days from randomization to clinical recovery
R1	DefinedAs Arg1:T1 Arg2:T2	
T3	OutcomeDefinition 267 544	met all of the following criteria for at least 48 hours: 1. axillary body temperature ≤36.9°C or oral body temperature ≤37.2°C; 2. complete relief of all symptoms other than cough; 3. cough graded as mild or absent on a patient-reported scale of severe, moderate, mild, absent.
R2	DefinedAs Arg1:T1 Arg2:T3	
T4	TimeFrame 587 600	up to 28 days
T5	TimeFrame 167 191	Maximum TTCR was 28 days
R3	MeasuredAt Arg1:T1 Arg2:T5	
T6	SecondaryOutcome 606 639	time to SARS-CoV-2 RNA negativity
T7	OutcomeDefinition 652 803	the time from randomization to the day of the first test in two consecutive tests of nasopharyngeal or oropharyngeal swabs with negative SARS-CoV-2 RNA
T8	SecondaryOutcome 808 831	length of hospital stay
T9	OutcomeDefinition 844 894	the number of days from randomization to discharge
T10	SecondaryOutcome 899 923	Changes on chest CT scan
T11	SecondaryOutcome 928 971	duration (days) of supplemental oxygenation
T12	SecondaryOutcome 976 1003	frequency of adverse events
T13	SecondaryOutcome 1008 1023	clinical status
T14	SecondaryOutcome 1028 1047	all-cause mortality
T15	SecondaryOutcome 1052 1095	duration (days) of supplemental oxygenation
T16	SecondaryOutcome 1100 1111	vital signs
T17	SecondaryOutcome 1117 1146	results of laboratory testing
R4	DefinedAs Arg1:T6 Arg2:T7	
R5	DefinedAs Arg1:T8 Arg2:T9	
R6	MeasuredAt Arg1:T6 Arg2:T4	
R7	MeasuredAt Arg1:T8 Arg2:T4	
R8	MeasuredAt Arg1:T10 Arg2:T4	
R9	MeasuredAt Arg1:T11 Arg2:T4	
R10	MeasuredAt Arg1:T12 Arg2:T4	
R11	MeasuredAt Arg1:T13 Arg2:T4	
R12	MeasuredAt Arg1:T14 Arg2:T4	
R13	MeasuredAt Arg1:T15 Arg2:T4	
R14	MeasuredAt Arg1:T16 Arg2:T4	
R15	MeasuredAt Arg1:T17 Arg2:T4	
T18	OutcomeDefinition 1159 1288	semi-quantitative scoring system similar to the method reported by Pan et al. to estimate the pulmonary manifestations on CT scan
R16	DefinedAs Arg1:T10 Arg2:T18	
T19	OtherOutcome 1555 1581	Changes in cytokine levels
T20	OtherOutcome 1586 1618	COVID-19-specific IgG/IgM levels
T21	TimeFrame 1644 1673	first week of hospitalization
R17	MeasuredAt Arg1:T19 Arg2:T21	
R18	MeasuredAt Arg1:T20 Arg2:T21	
